New Anti-SARS-CoV-2 ELISA kits

DBC Anti-SARS-CoV-2 IgG ELISA, and DBC Anti-SARS-CoV-2 Total Antibody ELISA

DBC has received Health Canada COVID-19 Medical Device Authorization for the sale of its Anti-SARS-CoV-2 Total Antibody ELISA Kit and Anti-SARS-CoV-2 IgG ELISA Kit in Canada.

The DBC Anti-SARS-CoV-2 Total Antibody kit is a qualitative ELISA test intended for the detection of total antibodies (IgA, IgG and IgM) to SARS-CoV-2 in human serum or K2/K3 EDTA plasma from the adult population.

The DBC Anti-SARS-CoV-2 IgG kit is a qualitative ELISA test intended for the detection of IgG antibodies to SARS-CoV-2 in human serum or K2/K3 EDTA plasma from the adult population.

Both kits are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. These tests may also detect a response to vaccination.

Contact DBC for more information about these new kits, and how to order:

Anti-SARS-CoV-2 Total Antibody (Ab) ELISA Kit   CAN-IGT-19
Anti-SARS-CoV-2 IgG ELISA Kit   CAN-IGG-19